Jump to content

Experimental COVID-19 drug shows promise in new study


perugu_vada

Recommended Posts

https://apple.news/AEWt2-WQsRQqsuiR8-U2WPQ
 

According to a report published in the New England Journal of Medicine, Gilead Sciences Inc.’s experimental drug remdesivir was able to effectively treat a number of patients in the U.S., Europe and Canada who needed respiratory support.
 

Of the 53 patients, 36 saw an improvement in oxygen-support class. Twenty-five people were discharged, while seven died. Mortality was particularly high among those who were on a ventilator.
 

"These early data from 53 patients have not been generated in a clinical trial and cover only a small portion of the critically ill patients who have been treated with remdesivir."

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...